50 likes | 63 Views
Access Complete Report at - https://www.theinsightpartners.com/reports/active-implantable-medical-devices-market<br><br>The increasing prevalence of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements & new product launches and large pool of geriatric population are the major factors that anticipated to propel the growth for the active implantable medical devices market in the forecast period. However, the high cost of products and procedures and high rate of product recalls is expected to act as major challenges hindering the market growth at certain extent. <br>
E N D
Active Implantable Medical Devices Market Publication Month: Oct 2018 | No. of Pages: 144 | Report Code: TIPMD00002232 | Category: Medical Device Active Implantable Medical Devices Market to 2025 - Global Analysis and Forecasts By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, and Implantable Hearing Devices), End-User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) and Geography E-Mail : sales@theinsightpartners.com
Active Implantable Medical Devices Market Publication Month: Oct 2018 | No. of Pages: 144 | Report Code: TIPMD00002232 | Category: Medical Device Introduction: Active medical device means a medical device that depends on the function of an electrical energy source or other power source other than the energy directly generated by the human body or gravity and acts by converting this energy. The report highlights the trends prevalent in the global active implantable medical devices market and the factors driving the market along with those that act as deterrents to its growth. Europe is was the second largest geographic market and it is expected to be the second highest revenue contributor throughout the forecast period. Europe market is driven by the factors such as frequent product launches and increasing awareness among the population in the region. Additionally, rising chronic conditions and increasing government initiatives for healthcare are some major factors have that influence the European active implantable medical devices market. E-Mail : sales@theinsightpartners.com
Active Implantable Medical Devices Market Publication Month: Oct 2018 | No. of Pages: 144 | Report Code: TIPMD00002232 | Category: Medical Device The increasing prevalence of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements & new product launches and large pool of geriatric population are the major factors that anticipated to propel the growth for the active implantable medical devices market in the forecast period. However, the high cost of products and procedures and high rate of product recalls is expected to act as major challenges hindering the market growth at certain extent. Global active implantable medical devices market segmented into by product and end user. Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, neurostimulators, implantable hearing devices, ventricular assist devices and implantable heart monitors/insertable loop recorders. The implantable cardioverter defibrillators segment is further bifurcated into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators. On the basis of end user, the active implantable medical devices market classified as hospitals, ambulatory surgery centers and specialty clinics. E-Mail : sales@theinsightpartners.com
Active Implantable Medical Devices Market Publication Month: Oct 2018 | No. of Pages: 144 | Report Code: TIPMD00002232 | Category: Medical Device The high market growth is anticipated on account of the rising global geriatric population. The risk of cardiovascular diseases increases with increase in age, in both male and females. Increasing age makes the blood vessels less flexible and reduction in blood flow. Thus, the risk of heart disease is high in elder population. According to the Heart Disease and Stroke Statistics 2018, average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that annual incidence of heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. Similarly, rising prevalence of the neurological disorders in the geriatric population is expected to serve as a high impact rendering driver for the active implantable medical devices market over the forecast period. According to the Alzheimer's Association, in 2018, 5.7 million Americans suffer from Alzheimer's dementia of which 5.5 million are people with age 65 and older. Furthermore, the United Nations in 2017, estimated 962 million people are aged 60 or over across the globe and is increasing by 3% every year. It also stated that the elder population with 60 and more age worldwide is projected to be 1.4 billion in 2030 and 2.1 billion in 2050, and could rise to 3.1 billion in 2100. Hence, the increasing global geriatric population is likely to boost the market growth during the forecast period. Get a PDF Sample copy of Active Implantable Medical Devices Market: https://www.theinsightpartners.com/sample/TIPMD00002232/ E-Mail : sales@theinsightpartners.com
Active Implantable Medical Devices Market Publication Month: Oct 2018 | No. of Pages: 144 | Report Code: TIPMD00002232 | Category: Medical Device • Major Key Players Involving in this study: • 1. Medtronic • 2. ABBOTT • 3. Cochlear Ltd. • 4. Boston Scientific Corporation • 5. BIOTRONIK • 6. MED-EL • 7. SONOVA • 8. William Demant Holding A/S • 9. LivaNova PLC • 10. Nurotron Biotechnology Co. Ltd. • Inquire more @ https://www.theinsightpartners.com/inquiry/TIPMD00002232/ E-Mail : sales@theinsightpartners.com